Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | French |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.18115689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866901824974356480 |
|---|---|
| author | Pillet, Xavier |
| author_facet | Pillet, Xavier |
| contents | <p><strong>Résumé FR</strong><br>Ce document, produit avec l’assistance de ChatGPT 5.2 Thinking et Gemini 3 Raisonnement, est publié sous licence Apache 2.0. Il constitue une publication défensive (antériorité) et entre de ce fait dans l’état de la technique au sens des législations applicables : EPC Art. 54(2); French IPC Art. L 611-11; cf. 35 U.S.C. §102(a); Loi chinoise sur les brevets art. 22(5) (中华人民共和国专利法) et Loi japonaise sur les brevets art. 29(1) (特許法). Il divulgue de façon enabling des procédés de synthèse/purification d’Ag@C60 (arc, ablation laser, HPLC, centrifugation/CPC, recyclage solvants et argent), des méthodes QA/qualification (MS, HPLC, ICP, empreintes spectrales, TEM-EDX, tests extrêmes), et des systèmes applicatifs pour diagnostic ultra-précoce (biosenseurs plasmoniques, kits, CT/dual-modality, IA) et maintenance prédictive aérospatiale (revêtements capteurs, smart paint, jumeau numérique, apprentissage fédéré, ordonnancement). Chaque proposition est classifiée IPC/CPC et accompagnée d’une preuve d’horodatage (RFC 3161 / FreeTSA).</p> <p><strong>Abstract EN</strong><br>This document, produced with the assistance of ChatGPT 5.2 Thinking and Gemini 3 Raisonnement, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent statutes: (art. L 611-11 CPI / art. 54(2) CBE), 35 U.S.C. §102(a) (United States Patent Act), Chinese Patent Law Art. 22(5) (中华人民共和国专利法), and Japanese Patent Act Art. 29(1) (特許法). It enables Ag@C60 endohedral-fullerene production and deployment across (i) synthesis and purification (arc discharge, laser ablation, preparative HPLC, density-gradient/continuous centrifugation, CPC, solvent and silver recycling), (ii) QA and qualification (HR-MS, analytical HPLC, ICP-MS free-metal release, multimodal spectral fingerprints, TEM-EDX encapsulation proof, extreme pressure/thermal/vibration tests), and (iii) applications in ultra-early diagnostics (plasmonic biosensors, standardized kits, CT/dual-modality imaging, AI reconstruction) and aerospace predictive maintenance (conductive coatings, smart paint, telemetry standards, digital twins, federated learning, closed-loop scheduling). Each proposal is enabling, IPC/CPC-classified, and timestamped (RFC 3161 / FreeTSA).</p> <p><strong>Timestamp:</strong> 2026-01-01T12:33:29Z<br><strong>SHA-256:</strong> 5345e809e5c8bdd4aa23bcd8be10378538249bef505715d9fee259cb2448a06b</p> <p><strong>Liste des innovations & classification (IPC ; CPC)</strong><br>1. Ag@C60 arc process mapping — IPC C01B 31/02 ; CPC C01B 31/02<br>2. Ag@C60 laser target recipe — IPC C01B 31/02 ; CPC C01B 31/02<br>3. Low-oxygen composite anode — IPC C01B 31/02 ; CPC C01B 31/02<br>4. Green extraction with recycling — IPC B01D 11/04 ; CPC B01D 11/04<br>5. Multi-column prep HPLC line — IPC B01D 15/08 ; CPC B01D 15/08<br>6. Density-gradient ultracentrifugation — IPC B04B 1/00 ; CPC B04B 1/00<br>7. Continuous-flow centrifugation — IPC B04B 9/00 ; CPC B04B 9/00<br>8. Silver recovery from residues — IPC C22B 3/00 ; CPC C22B 3/00<br>9. 99.9% multi-tech QC release — IPC G01N 30/74 ; CPC G01N 30/74<br>10. Extreme-pressure cage test — IPC G01N 3/08 ; CPC G01N 3/08<br>11. Vibration/thermal cage qualification — IPC G01M 7/00 ; CPC G01M 7/00<br>12. Flexible SPCE Ag@C60 biosensor — IPC G01N 21/64 ; CPC G01N 21/64<br>13. Pre-analytical standard kit — IPC C12Q 1/68 ; CPC C12Q 1/68<br>14. Ag@C60 lateral-flow label — IPC G01N 33/53 ; CPC G01N 33/53<br>15. PEGylated Ag@C60 CT contrast — IPC A61K 9/127 ; CPC A61K 9/127<br>16. Low-dose CT reconstruction AI — IPC G06N 20/00 ; CPC G06T 7/00<br>17. Dual-modality CT+NIR workflow — IPC A61B 6/00 ; CPC A61B 6/00<br>18. Turbine crack-sensing coating — IPC G01L 1/22 ; CPC G01L 1/22<br>19. RFID smart paint SHM network — IPC G01M 13/00 ; CPC G01M 13/00<br>20. EMF fleet digital twin — IPC G06Q 10/06 ; CPC G06Q 10/06<br>21. Federated learning across fleets — IPC G06N 20/00 ; CPC G06F 21/62<br>22. Closed-loop maintenance scheduler — IPC G06Q 10/08 ; CPC G06Q 10/083<br>23. Diagnostic micro-dose protocol — IPC A61K 31/00 ; CPC A61K 31/00<br>24. Liposomal Ag@C60 injectable — IPC A61K 9/127 ; CPC A61K 9/127<br>25. Oral oil Ag@C60 formulation — IPC A61K 9/08 ; CPC A61K 9/08<br>26. Microneedle patch closed-loop — IPC A61M 37/00 ; CPC A61M 37/00<br>27. Anti-inflammatory implant coating — IPC A61L 27/00 ; CPC A61L 27/00<br>28. Ag@C60 photothermal theranostics — IPC A61N 5/06 ; CPC A61N 5/06<br>29. Antimicrobial photodynamic hydrogel — IPC A61L 2/18 ; CPC A61L 2/18<br>30. Nanoparticle LCA dashboard — IPC G06Q 50/00 ; CPC G06Q 50/06<br>31. DICOM-EMF metadata extension — IPC G16H 10/60 ; CPC G16H 10/60<br>32. Secure aerospace telemetry schema — IPC G06F 16/00 ; CPC G06F 16/27<br>33. Clinical triage workflow UX — IPC A61B 5/00 ; CPC G16H 40/67<br>34. Explainable MRO alerts UI — IPC G06Q 10/08 ; CPC G06Q 10/083<br>35. Traceable solvent/lot packaging — IPC B65D 55/02 ; CPC B65D 55/02<br>36. Cold-chain for formulations — IPC G06Q 10/08 ; CPC G06Q 10/083<br>37. Calibration-as-a-service metrology — IPC G06Q 10/06 ; CPC G06Q 10/063<br>38. Performance-based MRO contracting — IPC G06Q 40/08 ; CPC G06Q 40/08<br>39. Closed-loop helium for arcs — IPC F17C 11/00 ; CPC F17C 11/00<br>40. CO ventilation safety interlock — IPC G08B 21/00 ; CPC G08B 21/00<br>41. Automated moving anode feed — IPC H05B 7/18 ; CPC H05B 7/18<br>42. OES plasma closed-loop control — IPC G01N 21/63 ; CPC G01N 21/63<br>43. Ni/Cu catalytic anode dopant — IPC C01B 31/02 ; CPC C01B 31/02<br>44. Antisolvent colloid generator — IPC B04B 1/00 ; CPC B04B 1/00<br>45. Vacuum distillation solvent recycle QA — IPC B01D 3/14 ; CPC B01D 3/14<br>46. Temperature-controlled centrifugation — IPC B04B 15/00 ; CPC B04B 15/00<br>47. Continuous CPC fullerene separation — IPC B01D 15/08 ; CPC B01D 15/08<br>48. C60/C70 coproduct monetization — IPC C01B 31/02 ; CPC C01B 31/02<br>49. TEM-EDX encapsulation proof QC — IPC G01N 23/04 ; CPC G01N 23/04<br>50. Multimodal spectral lot fingerprint — IPC G01N 21/27 ; CPC G01N 21/27<br>51. Formulation-dependent PK protocol — IPC A61K 9/127 ; CPC A61K 9/127<br>52. Fullerene wastewater capture train — IPC C02F 1/28 ; CPC C02F 1/28<br>53. Sealed QA sample chain-of-custody — IPC G06Q 10/08 ; CPC G06Q 10/083<br>54. MeTHF antisolvent gradient — IPC B04B 1/00 ; CPC B04B 1/00<br>55. Terpene solvent screening SOP — IPC G01N 30/74 ; CPC G01N 30/74<br>56. C60 coproduct crystallization line — IPC C01B 31/02 ; CPC C01B 31/02<br>57. Modular parallel arc CAPEX design — IPC H05B 7/18 ; CPC H05B 7/18<br>58. Arc heat recovery to distillation — IPC F28D 1/00 ; CPC F28D 1/00<br>59. Inline ICP micro-sampling — IPC G01N 21/85 ; CPC G01N 21/85<br>60. Lipid droplet loading uniformity — IPC A61K 9/127 ; CPC A61K 9/127<br>61. Passive PEGylated liposomes — IPC A61K 9/127 ; CPC A61K 9/127<br>62. Injectable MCT nanoemulsion — IPC A61K 9/127 ; CPC A61K 9/127<br>63. Vitamin E co-formulation — IPC A61K 31/355 ; CPC A61K 31/355<br>64. CoQ10/melatonin co-formulation — IPC A61K 31/35 ; CPC A61K 31/35<br>65. Porphyrin--Ag@C60 PDT complex — IPC A61N 5/06 ; CPC A61N 5/06<br>66. Ag@C60 FRET ROS sensor — IPC G01N 21/64 ; CPC G01N 21/64<br>67. Core--shell heating + scavenging — IPC A61N 5/06 ; CPC A61N 5/06<br>68. Protected radiosensitization method — IPC A61N 5/10 ; CPC A61N 5/10<br>69. Mitochondrial organelle imaging — IPC A61B 6/00 ; CPC A61B 6/00<br>70. Ag@C60-doped neural electrode — IPC A61N 1/36 ; CPC A61N 1/36<br>71. Light-activated antibiofilm implant — IPC A61L 2/18 ; CPC A61L 2/18<br>72. Dual-mode LED wound dressing — IPC A61L 15/44 ; CPC A61L 15/44<br>73. Standardized multi-form tox panel — IPC G01N 33/50 ; CPC G01N 33/50<br>74. Carbide/alloy low-O2 anode feed — IPC C01B 31/02 ; CPC C01B 31/02</p> <p><strong>Keywords</strong><br>MeTHF antisolvent gradient, terpene solvent screening, C60 crystallization coproduct, modular arc reactors, heat recovery distillation, inline ICP-MS free metal, droplet loading homogeneity, PEGylated liposomes, MCT injectable emulsion, vitamin E coformulation, CoQ10 melatonin synergy, porphyrin complex PDT, FRET ROS sensor, core-shell plasmonic heating, protected radiosensitization, mitochondria organelle imaging, neural electrode composite, implant antibiofilm photothermal, dual-mode LED wound dressing, formulation-dependent toxicology, metal-carbide electrode</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18115689 |
| institution | Zenodo |
| language | fra |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Rapport sur le déploiement du marché des fullerènes endohédraux Ag@C60 Pillet, Xavier MeTHF antisolvent gradient terpene solvent screening C60 crystallization coproduct modular arc reactors heat recovery distillation inline ICP-MS free metal droplet loading homogeneity PEGylated liposomes MCT injectable emulsion vitamin E coformulation CoQ10 melatonin synergy porphyrin complex PDT FRET ROS sensor core-shell plasmonic heating protected radiosensitization mitochondria organelle imaging neural electrode composite implant antibiofilm photothermal dual-mode LED wound dressing formulation-dependent toxicology metal-carbide C01B 31/02 B01D 11/04 B01D 15/08 B04B 1/00 B04B 9/00 C22B 3/00 G01N 30/74 G01N 3/08 G01M 7/00 G01N 21/64 C12Q 1/68 G01N 33/53 A61K 9/127 G06N 20/00 A61B 6/00 G01L 1/22 G01M 13/00 G06Q 10/06 G06Q 10/08 A61K 31/00 A61K 9/08 A61M 37/00 A61L 27/00 A61N 5/06 A61L 2/18 G06Q 50/00 G16H 10/60 G06F 16/00 A61B 5/00 B65D 55/02 G06Q 40/08 F17C 11/00 G08B 21/00 H05B 7/18 G01N 21/63 B01D 3/14 B04B 15/00 G01N 23/04 G01N 21/27 C02F 1/28 G01N 21/85 A61K 31/355 A61K 31/35 A61N 5/10 A61N 1/36 A61L 15/44 G01N 33/50 F28D 1/00 <p><strong>Résumé FR</strong><br>Ce document, produit avec l’assistance de ChatGPT 5.2 Thinking et Gemini 3 Raisonnement, est publié sous licence Apache 2.0. Il constitue une publication défensive (antériorité) et entre de ce fait dans l’état de la technique au sens des législations applicables : EPC Art. 54(2); French IPC Art. L 611-11; cf. 35 U.S.C. §102(a); Loi chinoise sur les brevets art. 22(5) (中华人民共和国专利法) et Loi japonaise sur les brevets art. 29(1) (特許法). Il divulgue de façon enabling des procédés de synthèse/purification d’Ag@C60 (arc, ablation laser, HPLC, centrifugation/CPC, recyclage solvants et argent), des méthodes QA/qualification (MS, HPLC, ICP, empreintes spectrales, TEM-EDX, tests extrêmes), et des systèmes applicatifs pour diagnostic ultra-précoce (biosenseurs plasmoniques, kits, CT/dual-modality, IA) et maintenance prédictive aérospatiale (revêtements capteurs, smart paint, jumeau numérique, apprentissage fédéré, ordonnancement). Chaque proposition est classifiée IPC/CPC et accompagnée d’une preuve d’horodatage (RFC 3161 / FreeTSA).</p> <p><strong>Abstract EN</strong><br>This document, produced with the assistance of ChatGPT 5.2 Thinking and Gemini 3 Raisonnement, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent statutes: (art. L 611-11 CPI / art. 54(2) CBE), 35 U.S.C. §102(a) (United States Patent Act), Chinese Patent Law Art. 22(5) (中华人民共和国专利法), and Japanese Patent Act Art. 29(1) (特許法). It enables Ag@C60 endohedral-fullerene production and deployment across (i) synthesis and purification (arc discharge, laser ablation, preparative HPLC, density-gradient/continuous centrifugation, CPC, solvent and silver recycling), (ii) QA and qualification (HR-MS, analytical HPLC, ICP-MS free-metal release, multimodal spectral fingerprints, TEM-EDX encapsulation proof, extreme pressure/thermal/vibration tests), and (iii) applications in ultra-early diagnostics (plasmonic biosensors, standardized kits, CT/dual-modality imaging, AI reconstruction) and aerospace predictive maintenance (conductive coatings, smart paint, telemetry standards, digital twins, federated learning, closed-loop scheduling). Each proposal is enabling, IPC/CPC-classified, and timestamped (RFC 3161 / FreeTSA).</p> <p><strong>Timestamp:</strong> 2026-01-01T12:33:29Z<br><strong>SHA-256:</strong> 5345e809e5c8bdd4aa23bcd8be10378538249bef505715d9fee259cb2448a06b</p> <p><strong>Liste des innovations & classification (IPC ; CPC)</strong><br>1. Ag@C60 arc process mapping — IPC C01B 31/02 ; CPC C01B 31/02<br>2. Ag@C60 laser target recipe — IPC C01B 31/02 ; CPC C01B 31/02<br>3. Low-oxygen composite anode — IPC C01B 31/02 ; CPC C01B 31/02<br>4. Green extraction with recycling — IPC B01D 11/04 ; CPC B01D 11/04<br>5. Multi-column prep HPLC line — IPC B01D 15/08 ; CPC B01D 15/08<br>6. Density-gradient ultracentrifugation — IPC B04B 1/00 ; CPC B04B 1/00<br>7. Continuous-flow centrifugation — IPC B04B 9/00 ; CPC B04B 9/00<br>8. Silver recovery from residues — IPC C22B 3/00 ; CPC C22B 3/00<br>9. 99.9% multi-tech QC release — IPC G01N 30/74 ; CPC G01N 30/74<br>10. Extreme-pressure cage test — IPC G01N 3/08 ; CPC G01N 3/08<br>11. Vibration/thermal cage qualification — IPC G01M 7/00 ; CPC G01M 7/00<br>12. Flexible SPCE Ag@C60 biosensor — IPC G01N 21/64 ; CPC G01N 21/64<br>13. Pre-analytical standard kit — IPC C12Q 1/68 ; CPC C12Q 1/68<br>14. Ag@C60 lateral-flow label — IPC G01N 33/53 ; CPC G01N 33/53<br>15. PEGylated Ag@C60 CT contrast — IPC A61K 9/127 ; CPC A61K 9/127<br>16. Low-dose CT reconstruction AI — IPC G06N 20/00 ; CPC G06T 7/00<br>17. Dual-modality CT+NIR workflow — IPC A61B 6/00 ; CPC A61B 6/00<br>18. Turbine crack-sensing coating — IPC G01L 1/22 ; CPC G01L 1/22<br>19. RFID smart paint SHM network — IPC G01M 13/00 ; CPC G01M 13/00<br>20. EMF fleet digital twin — IPC G06Q 10/06 ; CPC G06Q 10/06<br>21. Federated learning across fleets — IPC G06N 20/00 ; CPC G06F 21/62<br>22. Closed-loop maintenance scheduler — IPC G06Q 10/08 ; CPC G06Q 10/083<br>23. Diagnostic micro-dose protocol — IPC A61K 31/00 ; CPC A61K 31/00<br>24. Liposomal Ag@C60 injectable — IPC A61K 9/127 ; CPC A61K 9/127<br>25. Oral oil Ag@C60 formulation — IPC A61K 9/08 ; CPC A61K 9/08<br>26. Microneedle patch closed-loop — IPC A61M 37/00 ; CPC A61M 37/00<br>27. Anti-inflammatory implant coating — IPC A61L 27/00 ; CPC A61L 27/00<br>28. Ag@C60 photothermal theranostics — IPC A61N 5/06 ; CPC A61N 5/06<br>29. Antimicrobial photodynamic hydrogel — IPC A61L 2/18 ; CPC A61L 2/18<br>30. Nanoparticle LCA dashboard — IPC G06Q 50/00 ; CPC G06Q 50/06<br>31. DICOM-EMF metadata extension — IPC G16H 10/60 ; CPC G16H 10/60<br>32. Secure aerospace telemetry schema — IPC G06F 16/00 ; CPC G06F 16/27<br>33. Clinical triage workflow UX — IPC A61B 5/00 ; CPC G16H 40/67<br>34. Explainable MRO alerts UI — IPC G06Q 10/08 ; CPC G06Q 10/083<br>35. Traceable solvent/lot packaging — IPC B65D 55/02 ; CPC B65D 55/02<br>36. Cold-chain for formulations — IPC G06Q 10/08 ; CPC G06Q 10/083<br>37. Calibration-as-a-service metrology — IPC G06Q 10/06 ; CPC G06Q 10/063<br>38. Performance-based MRO contracting — IPC G06Q 40/08 ; CPC G06Q 40/08<br>39. Closed-loop helium for arcs — IPC F17C 11/00 ; CPC F17C 11/00<br>40. CO ventilation safety interlock — IPC G08B 21/00 ; CPC G08B 21/00<br>41. Automated moving anode feed — IPC H05B 7/18 ; CPC H05B 7/18<br>42. OES plasma closed-loop control — IPC G01N 21/63 ; CPC G01N 21/63<br>43. Ni/Cu catalytic anode dopant — IPC C01B 31/02 ; CPC C01B 31/02<br>44. Antisolvent colloid generator — IPC B04B 1/00 ; CPC B04B 1/00<br>45. Vacuum distillation solvent recycle QA — IPC B01D 3/14 ; CPC B01D 3/14<br>46. Temperature-controlled centrifugation — IPC B04B 15/00 ; CPC B04B 15/00<br>47. Continuous CPC fullerene separation — IPC B01D 15/08 ; CPC B01D 15/08<br>48. C60/C70 coproduct monetization — IPC C01B 31/02 ; CPC C01B 31/02<br>49. TEM-EDX encapsulation proof QC — IPC G01N 23/04 ; CPC G01N 23/04<br>50. Multimodal spectral lot fingerprint — IPC G01N 21/27 ; CPC G01N 21/27<br>51. Formulation-dependent PK protocol — IPC A61K 9/127 ; CPC A61K 9/127<br>52. Fullerene wastewater capture train — IPC C02F 1/28 ; CPC C02F 1/28<br>53. Sealed QA sample chain-of-custody — IPC G06Q 10/08 ; CPC G06Q 10/083<br>54. MeTHF antisolvent gradient — IPC B04B 1/00 ; CPC B04B 1/00<br>55. Terpene solvent screening SOP — IPC G01N 30/74 ; CPC G01N 30/74<br>56. C60 coproduct crystallization line — IPC C01B 31/02 ; CPC C01B 31/02<br>57. Modular parallel arc CAPEX design — IPC H05B 7/18 ; CPC H05B 7/18<br>58. Arc heat recovery to distillation — IPC F28D 1/00 ; CPC F28D 1/00<br>59. Inline ICP micro-sampling — IPC G01N 21/85 ; CPC G01N 21/85<br>60. Lipid droplet loading uniformity — IPC A61K 9/127 ; CPC A61K 9/127<br>61. Passive PEGylated liposomes — IPC A61K 9/127 ; CPC A61K 9/127<br>62. Injectable MCT nanoemulsion — IPC A61K 9/127 ; CPC A61K 9/127<br>63. Vitamin E co-formulation — IPC A61K 31/355 ; CPC A61K 31/355<br>64. CoQ10/melatonin co-formulation — IPC A61K 31/35 ; CPC A61K 31/35<br>65. Porphyrin--Ag@C60 PDT complex — IPC A61N 5/06 ; CPC A61N 5/06<br>66. Ag@C60 FRET ROS sensor — IPC G01N 21/64 ; CPC G01N 21/64<br>67. Core--shell heating + scavenging — IPC A61N 5/06 ; CPC A61N 5/06<br>68. Protected radiosensitization method — IPC A61N 5/10 ; CPC A61N 5/10<br>69. Mitochondrial organelle imaging — IPC A61B 6/00 ; CPC A61B 6/00<br>70. Ag@C60-doped neural electrode — IPC A61N 1/36 ; CPC A61N 1/36<br>71. Light-activated antibiofilm implant — IPC A61L 2/18 ; CPC A61L 2/18<br>72. Dual-mode LED wound dressing — IPC A61L 15/44 ; CPC A61L 15/44<br>73. Standardized multi-form tox panel — IPC G01N 33/50 ; CPC G01N 33/50<br>74. Carbide/alloy low-O2 anode feed — IPC C01B 31/02 ; CPC C01B 31/02</p> <p><strong>Keywords</strong><br>MeTHF antisolvent gradient, terpene solvent screening, C60 crystallization coproduct, modular arc reactors, heat recovery distillation, inline ICP-MS free metal, droplet loading homogeneity, PEGylated liposomes, MCT injectable emulsion, vitamin E coformulation, CoQ10 melatonin synergy, porphyrin complex PDT, FRET ROS sensor, core-shell plasmonic heating, protected radiosensitization, mitochondria organelle imaging, neural electrode composite, implant antibiofilm photothermal, dual-mode LED wound dressing, formulation-dependent toxicology, metal-carbide electrode</p> |
| title | Rapport sur le déploiement du marché des fullerènes endohédraux Ag@C60 |
| topic | MeTHF antisolvent gradient terpene solvent screening C60 crystallization coproduct modular arc reactors heat recovery distillation inline ICP-MS free metal droplet loading homogeneity PEGylated liposomes MCT injectable emulsion vitamin E coformulation CoQ10 melatonin synergy porphyrin complex PDT FRET ROS sensor core-shell plasmonic heating protected radiosensitization mitochondria organelle imaging neural electrode composite implant antibiofilm photothermal dual-mode LED wound dressing formulation-dependent toxicology metal-carbide C01B 31/02 B01D 11/04 B01D 15/08 B04B 1/00 B04B 9/00 C22B 3/00 G01N 30/74 G01N 3/08 G01M 7/00 G01N 21/64 C12Q 1/68 G01N 33/53 A61K 9/127 G06N 20/00 A61B 6/00 G01L 1/22 G01M 13/00 G06Q 10/06 G06Q 10/08 A61K 31/00 A61K 9/08 A61M 37/00 A61L 27/00 A61N 5/06 A61L 2/18 G06Q 50/00 G16H 10/60 G06F 16/00 A61B 5/00 B65D 55/02 G06Q 40/08 F17C 11/00 G08B 21/00 H05B 7/18 G01N 21/63 B01D 3/14 B04B 15/00 G01N 23/04 G01N 21/27 C02F 1/28 G01N 21/85 A61K 31/355 A61K 31/35 A61N 5/10 A61N 1/36 A61L 15/44 G01N 33/50 F28D 1/00 |
| url | https://doi.org/10.5281/zenodo.18115689 |